iGyaan Network (blog)Human Embryos Edited For The First Time In The US-Using CRISPRiGyaan Network (blog)Recent reports show that researchers in the US have been successful in their first attempt at creating genetically modified human embryos. This rese… Continue reading
New Atlas |
CRISPR-treated skin graft used to treat diabetes in mice
New Atlas While the development of the CRISPR gene editing system is turning into one of the biggest scientific breakthroughs of the century, there are still many hurdles to overcome before the technology is efficiently applied in people. One big problem is … CRISPR skin grafts could replace insulin injections for diabetes …New Scientist CRISPR Gene Therapy via Skin Grafts Treats Obesity and Diabetes in MiceGenetic Engineering & Biotechnology News Gene therapy via skin could treat many diseases, even obesityScience Daily CNBC all 11 news articles » |
New Atlas |
CRISPR-treated skin graft used to treat diabetes in mice
New Atlas While the development of the CRISPR gene editing system is turning into one of the biggest scientific breakthroughs of the century, there are still many hurdles to overcome before the technology is efficiently applied in people. One big problem is … CRISPR skin grafts could replace insulin injections for diabetes …New Scientist CRISPR Gene Therapy via Skin Grafts Treats Obesity and Diabetes in MiceGenetic Engineering & Biotechnology News Gene therapy via skin could treat many diseases, even obesityScience Daily CNBC all 11 news articles » |
|
Merck to get European patent for CRISPR technology
pharmabiz.com Merck, a leading science and technology company, announced the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for Merck’s patent application covering the company’s CRISPR technology used in a genomic integration method for … |
|
Merck to get European patent for CRISPR technology
pharmabiz.com Merck, a leading science and technology company, announced the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for Merck’s patent application covering the company’s CRISPR technology used in a genomic integration method for … |